A series of novel MMP-13 and TNF-alpha converting enzyme inhibitors based on piperazine 2-hydroxamic acid scaffolds are described. The TACE, MMP-1 and MMP-13 activity of these inhibitors as well as the effect of substitution of the piperazine nitrogen and the P-1' benzyloxy tailpiece is discussed. Moderate in vivo activity is observed with several members of this group.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0960-894x(03)00666-8 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!